Formulation and Clinical Efficacy of Myrrh Extract in Hard Gelatin Capsules

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorHashem F.M.
dc.contributor.authorMassoud A.M.A.
dc.contributor.authorMelokheya A.M.
dc.contributor.authorEmad H.
dc.contributor.authorAbd El-Fattah Badr K.
dc.contributor.authorDawoud M.
dc.contributor.otherDepartment of Pharmaceutics and Industrial Pharmacy
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherHelwan-University
dc.contributor.otherCairo
dc.contributor.otherEgypt; Department of Tropical Medicine
dc.contributor.otherFaculty of Medicine
dc.contributor.otherAl-Azhar University
dc.contributor.otherCairo
dc.contributor.otherEgypt; National Organization for Drug Control and Research
dc.contributor.otherCairo
dc.contributor.otherEgypt; Department of Pharmaceutics
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherModern Science and Arts University
dc.contributor.otherCairo
dc.contributor.otherEgypt
dc.date.accessioned2020-01-09T20:42:27Z
dc.date.available2020-01-09T20:42:27Z
dc.date.issued2013
dc.descriptionScopus
dc.description.abstractThe development of myrrh extract from natural origin capable of eradication of schistosomal infections has gained the interest of many scientists. Recently; myrrh extract is considered as the drug of choice from natural origin used to treat Schistosomiasis. This work includes the preparation of myrrh extract by maceration and the formulation of these extracts in hard gelatin capsules as a pharmaceutical dosage form followed by clinical investigation of the effectiveness of these capsules. As a result, myrrh extract capsules with different doses showed a variable effectiveness against Schistosoma mansoni (S. mansoni) with different severity but n-hexane extract capsules showed better effectiveness in comparison to alcohol extract capsules. The percent cure increased by increasing the treatment time. In additions the number of positive cases decreased by increasing the treatment time. On the contrary, increasing the severity of the infection from mild to heavy cases led to decrease the cure percent and increased the number of the positive cases. There was a significant reduction of infection intensity in cases which were incompletely cured. It could be concluded from these results that hard gelatin capsules of myrrh extract are highly effective as a pharmaceutical dosage form against Schistosomiasis. � 2013, Copyright Har Krishan Bhalla & Sons.en_US
dc.description.urihttps://www.scimagojr.com/journalsearch.php?q=21100902935&tip=sid&clean=0
dc.identifier.doihttps://doi.org/10.1080/22311866.2013.782763
dc.identifier.doiPubMed ID :
dc.identifier.issn22311866
dc.identifier.otherhttps://doi.org/10.1080/22311866.2013.782763
dc.identifier.otherPubMed ID :
dc.identifier.urihttps://t.ly/R02r5
dc.language.isoEnglishen_US
dc.publisherTaylor and Francis Ltd.en_US
dc.relation.ispartofseriesJournal of Biologically Active Products from Nature
dc.relation.ispartofseries3
dc.subjectOctober University for Modern Sciences and Arts
dc.subjectجامعة أكتوبر للعلوم الحديثة والآداب
dc.subjectUniversity of Modern Sciences and Arts
dc.subjectMSA University
dc.subjectClinical investigationen_US
dc.subjectCommiphora molmolen_US
dc.subjectSchistosomaen_US
dc.titleFormulation and Clinical Efficacy of Myrrh Extract in Hard Gelatin Capsulesen_US
dc.typeArticleen_US
dcterms.isReferencedByHotez, P.J., Zheng, F., Long-qi, X., Ming-gang, C., Shu-hua, X., Shu-xian, L., Blair, D., Davis, G.M., Emerging and reemerging helminthiases and the public health of China (1997) Emerg. Infect. Dis., 3 (3), pp. 303-310; Davis, A., Wegner, D.H., Multicentre trials of praziquantel in human schistosomiasis: design and techniques (1979) Bull. World Health Organ., 57 (5), pp. 767-771; Bennett, J.L., Day, T., Liang, F.T., Ismail, M., Farghaly, A., The development of resistance to anthelmintics: a perspective with an emphasis on the antischistosomal drug prazi- quantel (1997) Exp. Parasitol., 87 (3), pp. 260-267; Boisier, P., Ramarokoto, C.E., Ravaoalimalala, V.E., Rabarijaona, L., Serieye, J., Roux, J., Esterre, P., Reversibility of Schistosoma mansoni-associated morbidity after yearly mass praziquantel therapy: ultrasonographic assessment (1998) Trans R. Soc. Trop. Med. Hyg., 92 (4), pp. 451-453; Brindley, P.J., Drug resistance to schistosomicides and other anthelmintics of medical significance (1994) Acta Trop., 56 (2-3), pp. 213-231; Coles, G.C., Bruce, J.I., Kinoti, G.K., Mutahi, W.T., Dias, E.P., andKatz, N., Drug resistance in schistosomiasis (1986) Trans R. Soc. Trop. Med. Hyg., 80 (2), p. 347; Cunha, V.M., Noel, F., (Ca(2+)-Mg2+)ATPase in Schistosoma mansoni: evidence for heterogeneity and resistance to praziquantel (1998) Mem Inst Oswaldo Cruz., 93, pp. 181-182; Dias, L.C., Pedro, R.J., Rigo, E., Goto, M.M., Mafra, G.L., A human strain of Schistosoma mansoni resistant to schistosomicides (1978) Rev. Saude Publica., 12 (1), p. 110; Kusel, J., Hagan, P., Praziquantel-its use, cost and possible development of resistance (1999) Parasitol Today, 15 (9), pp. 352-354; Liang, Y.S., Coles, G.C., Doenhoff, M.J., Detection of praziquantel resistance in schistosomes (2000) Trop. Med. Int. Health., 5 (1), p. 72; Fallon, P.G., Mubarak, J.S., Fookes, R.E., Niang, M., Butterworth, A.E., Sturrock, R.F., Doenhoff, M.J., Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates (1997) Exp. Parasitol., 86 (1), pp. 29-36; Pereira, C., Fallon, P.G., Cornette, J., Capron, A., Doenhoff, M.J., Pierce, R.J., Alterations in cytochrome-c oxidase expression between praziquantel-resistant and susceptible strains of Schistosoma mansoni (1998) Parasitology., 117, pp. 63-73; Picquet, M., Vercruysse, J., Shaw, D.J., Diop, M., Ly, A., Efficacy of praziquantel against Schistosoma mansoni in northern Senegal (1998) Trans R. Soc. Trop. Med. Hyg., 92 (1), pp. 90-93; Stelma, F.F., Sall, S., Daff, B., Sow, S., Niang, M., Gryseels, B., Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low (1997) J. Infect. Dis., 176 (1), pp. 304-307; Stelma, F.F., Talla, I., Sow, S., Kongs, A., Niang, M., Polman, K., Deelder, A.M., Gryseels, B., Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni (1995) Am. J. Trop. Med. Hyg., 53 (2), pp. 167-170; Cioli, D., Pica Mattoccia, L., Genetic analysis of hycanthone resistance in Schisto- soma mansoni (1984) Am. J. Trop. Med. Hyg., 33 (1), pp. 80-88; Anwar, W.A., Au, W.W., Ramanujam, V.M., Legator, M.S., Enhancement of benzene clastogenicity by praziquantel in mice (1989) Mutat. Res., 222 (3), pp. 283-289; Ford, R.A., Api, A.M., Letizia, C.S., Monographs on fragrance raw materials (1992) Food Chem. Toxicol., 30; Al-Suwaidan, S.N., Gad el Rab, M.O., Al-Fakhiry, S., Al Hoqail, I.A., Al-Maziad, A., Sherif, A.B., Allergic contact dermatitis from myrrh, a topical herbal medicine used to promote healing (1998) Contact Dermatitis., 39 (3), p. 137; Anderson, C., Lis-Balchin, M., Kirk-Smith, M., Evaluation of massage with essential oils on childhood atopic eczema (2000) Phytother Res., 14 (6), pp. 452-456; Massoud, A.M., Labib, I.M., Larvicidal activity of Commiphora molmol against Culex pipiens and Aedes caspius larvae (2000) J, Egypt Soc, Parasitol., 30 (1), pp. 101-115; Claeson, P., Andersson, R., Samuelsson, G., T-cadinol: a pharmacologically active constituent of scented myrrh: introductory pharmacological characterization and high field 1H- and 13C-NMR data (1991) Planta Med., 57 (4), pp. 352-356; al-Harbi, M.M., Qureshi, S., Ahmed, M.M., Rafatullah, S., Shah, A.H., Effect of Commiphora molmol (oleo-gum-resin) on the cytological and biochemical changes induced by cyclophosphamide in mice (1994) Am. J. Chin. Med., 22 (1), pp. 77-82; Massoud, A.A., Hussein, H.M., Reda, M.A., el-Wakil, H.S., Maher, K.M., Mahmoudm, F.S., Schistosoma mansoni egg specific antibodies and circulating antigens: assessment of their validity in immunodiagnosis of schistosomiasis (2000) J. Egypt Soc. Parasitol., 30 (3), pp. 903-916; Frandsen, F., Discussion of the relationships between Schistosoma and their intermediate hosts, assessment of the degree of host-parasite compatibility and evaluation of schistosome taxonomy (1979) Z. Parasitenkd., 58 (3), pp. 275-296; EL Ashry, E.R.N., Salama, O., (2002) Colorimetric determination of crude powdered myrrh, purified myrrh extract, oily fraction, and its pharmaceutical dosage forms Spectroscopy Letters, 35, pp. 183-197. , Need to mention Journal name; Michelson, M.K., Azziz, F.A., Gamil, F.M., Wahid, A.A., Richards, F.O., Juranek, D.D., Habib, M.A., Spencer, H.C., Recent trends in the prevalence and distribution of schistosomiasis in the Nile delta region (1993) Am. J. Trop. Med. Hyg., 49 (1), pp. 76-87; Katz, N., Chaves, A., Pellegrino, J., A simple device for quantitative stool thick- smear technique in Schistosomiasis mansoni (1972) Rev. Inst. Med. Trop. Sao Paulo., 14 (6), pp. 397-400; Abdel-Wahab, M.F., Esmat, G., Ramzy, I., Narooz, S., Medhat, E., Ibrahim, M., El-Boraey, Y., Strickland, G.T., The epidemiology of schistosomiasis in Egypt: Fayoum Governo- rate (2000) Am. J. Trop Med. Hyg., 62 (2), pp. 55-64; El-Khoby, T., Galal, N., Fenwick, A., Barakat, R., El-Hawey, A., Nooman, Z., Habib, M., Gabr, N.S., The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates (2000) Am. J. Trop Med. Hyg., 62 (2), pp. 88-99; van der Werf, M.J., de Vlas, S.J., Brooker, S., Looman, C.W., Nagelkerke, N.J., Habbema, J.D., Engels, D., Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa (2003) Acta Trop., 86 (2-3), pp. 125-139; Hanus, L.O., Rezanka, T., Dembitsky, M.V., Moussaieff, A., Myrrh-Commiphora chemistry (2005) Biomed Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., 149 (1), pp. 3-27; Martin, L.K., Beaver, P.C., Evaluation of Kato thick-smear technique for quantitative diagnosis of helminth infections (1968) Am. J. Trop. Med. Hyg., 17 (3), pp. 382-391
dcterms.sourceScopus

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
avatar_scholar_256.png
Size:
6.31 KB
Format:
Portable Network Graphics
Description:
Loading...
Thumbnail Image
Name:
Formulation and Clinical Efficacy of Myrrh Extract in Hard Gelatin Capsules (1) (1).pdf
Size:
706.75 KB
Format:
Adobe Portable Document Format
Description: